Molecular Partners AG ADR
Price & Volume
Stats
See more52W Range | $3.36-$5.91 |
Market Cap | $160M |
Shares Short | 26,423 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$40.4M |
Diluted EPS | -$2.01 |
News
See moreYahoo Finance • 6 days ago
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
Yahoo Finance • last month
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
Yahoo Finance • last month
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
About
CEO | Dr. Patrick Amstutz Ph.D. |
Address | Wagistrasse 14, Schlieren, Switzerland, 8952 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 158 |
